Amikacin
"Amikacin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A broad-spectrum antibiotic derived from KANAMYCIN. It is reno- and oto-toxic like the other aminoglycoside antibiotics.
Descriptor ID |
D000583
|
MeSH Number(s) |
D09.408.051.476.060
|
Concept/Terms |
Yectamid- Yectamid
- Collins Brand of Amikacin Sulfate
Amikacina Medical- Amikacina Medical
- Medical, Amikacina
- Medical Brand of Amikacin Sulfate
Amikacina Normon- Amikacina Normon
- Normon, Amikacina
- Norman Brand of Amikacin Sulfate
Amikafur- Amikafur
- Fustery Brand of Amikacin Sulfate
Amikalem- Amikalem
- Lemery Brand of Amikacin Sulfate
Amikason's- Amikason's
- Son's Brand of Amikacin Sulfate
Amikayect- Amikayect
- Grossmann Brand of Amikacin Sulfate
Amikin- Amikin
- Amukin
- Mead Johnson Brand of Amikacin Sulfate
- Biclin
- Biklin
- Bristol-Myers Squibb Brand of Amikacin Sulfate
- Bristol Myers Squibb Brand of Amikacin Sulfate
- Amiklin
- Apothecon Brand of Amikacin Sulfate
BB-K8- BB-K8
- BB K8
- BBK8
- BB-K 8
- BB K 8
- BBK 8
Gamikal- Gamikal
- Galen Brand of Amikacin Sulfate
Kanbine- Kanbine
- Rovi Brand of Amikacin Sulfate
Oprad- Oprad
- Cryopharma Brand of Amikacin Sulfate
A.M.K- A.M.K
- Pisa Brand of Amikacin Sulfate
|
Below are MeSH descriptors whose meaning is more general than "Amikacin".
Below are MeSH descriptors whose meaning is more specific than "Amikacin".
This graph shows the total number of publications written about "Amikacin" by people in this website by year, and whether "Amikacin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2006 | 0 | 1 | 1 |
2014 | 1 | 0 | 1 |
2015 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Amikacin" by people in Profiles.
-
Ehsan Z, Clancy JP. Management of Pseudomonas aeruginosa infection in cystic fibrosis patients using inhaled antibiotics with a focus on nebulized liposomal amikacin. Future Microbiol. 2015; 10(12):1901-12.
-
Ehsan Z, Wetzel JD, Clancy JP. Nebulized liposomal amikacin for the treatment of Pseudomonas aeruginosa infection in cystic fibrosis patients. Expert Opin Investig Drugs. 2014 May; 23(5):743-9.
-
Taylor JB, Hogue LA, LiPuma JJ, Walter MJ, Brody SL, Cannon CL. Entry of Burkholderia organisms into respiratory epithelium: CFTR, microfilament and microtubule dependence. J Cyst Fibros. 2010 Jan; 9(1):36-43.
-
Thorell EA, Sharma M, Jackson MA, Selvarangan R, Woods GM. Disseminated nontuberculous mycobacterial infections in sickle cell anemia patients. J Pediatr Hematol Oncol. 2006 Oct; 28(10):678-81.